GWT is currently seeking a capital raise from interested medical device and alternative funding organizations with interest in FDA 510(k) approved FIRST to market, innovative synthetic barrier surgical and examination glove technology having similar fit and feel characteristics to NRL latex as well as replacing other inferior chemical based synthetic raw materials.

Potential serious investors are invited to contact the CEO & Operations Manager vr@globalwidetechnology.com directly for further information regarding this exciting opportunity being presented to the global medical glove industry.

GWT owns six licensed FDA 510(k) approved first to market synthetic polyisoprene surgical and examination glove formulations. The company produces surgical and examination powder free medical gloves that will be launched into a global $7Billion marketplace within 60 days. GWT uses a proprietary polymer surface coating technique that allows the user to double gloving on one hand, positioning itself on a course to change the medical, automotive, food handling, dentistry, EMT/Fire Police and industrial markets forever. These six special formulations are applied to polyisoprene, co-polymer and triblock raw materials that offer the end user with similar fit and feel characteristics as compared to NRL latex gloves, eliminating harmful proteins causing allergies and potential lawsuits from exposure.